Skip to content
Wenlo
Sign in
← Markets

Lexeo Therapeutics, Inc.

Tobin Schilke (Director) reports LXEO insider transactions

3LXEOFiled Nov 17, 2026, 12:53 PM ET· Period Nov 14, 2026

About this filing

Lexeo Therapeutics, Inc. (LXEO) filed Form 3 (initial insider holdings) with the SEC on Nov 17, 2026.

Key facts

Insider
Tobin Schilke · Director

No transactions reported; holdings only.

More LXEO filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.